Wed. Jan 22nd, 2025

AI-developed drug will be in trials by year-end, says Google’s Hassabis

Founder of Isomorphic Labs aims to develop a drug in oncology, cardiovascular or neurodegeneration areas   [#item_con

Founder of Isomorphic Labs aims to develop a drug in oncology, cardiovascular or neurodegeneration areas

 tent]

Read More

By FIXEDD

FIXEDD began as a personal website with a focus on construction topics. As it evolves, FIXEDD aims to become a valuable resource for AEC professionals, providing current industry news, software updates, and expert advice. With a vision to grow and make an impact.

Related Post

Leave a Reply

Your email address will not be published. Required fields are marked *